Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With Irinotecan

NCT00496704 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: capecitabine
DRUG: gemcitabine hydrochloride
DRUG: oxaliplatin

Sponsor

Yonsei University